Vimarsana
Biggest News Aggregation in the World

Page 13 - Pharmascience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmascience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmascience Inc Today - Breaking & Trending Today

Blood pressure medication recalled due to an impurity at unacceptable levels - Vimarsana News

Blood pressure medication recalled due to an impurity at unacceptable levels

A trio of high blood pressure medications are being recalled due to the presence of an impurity.

Health Canada recalls three blood pressure drugs from 'sartan' class - Vimarsana News

Health Canada recalls three blood pressure drugs from 'sartan' class

  WINNIPEG -- Health Canada has issued a recall covering three types of blood pressure drugs from the class of medication known as 'sartans.’ A news release from Health Canada lists the three drugs recalled, which are produced by several manufacturers, as irbesartan, losartan and valsartan. Sartans are prescribed to treat patients with high blood pressure to help prevent heart attacks and stroke. They are also used in patients with heart failure or those who have had a recent heart attack. Health Canada says people who have been prescribed these medications should still keep taking th...

COVID-19 - Lancet Respiratory Medicine publishes the Montreal Heart Institute's COLCORONA study - Vimarsana News

COVID-19 - Lancet Respiratory Medicine publishes the Montreal Heart Institute's COLCORONA study

Today the Lancet Respiratory Medicine published the results of the Montreal Heart Institute's (MHI) COLCORONA study on the prevention of morbidity and mortality related to COVID-19. Pharmascience Inc., one of the largest Canadian-owned pharmaceutical companies, has supported this study since its inception.

Source: yahoo.com
Results of the COLCORONA study published in The Lancet Respiratory Medicine Colchicine could be considered as a treatment for non-hospitalized patients diagnosed with COVID-19 by PCR test and at risk of complications - Vimarsana News

Results of the COLCORONA study published in The Lancet Respiratory Medicine Colchicine could be considered as a treatment for non-hospitalized patients diagnosed with COVID-19 by PCR test and at risk of complications

MONTREAL, May 28, 2021 (GLOBE NEWSWIRE) — The Montreal Heart Institute (MHI) announces that the COLCORONA study results are published in The Lancet…

Montreal Heart Institute: Results of the COLCORONA study published in The Lancet Respiratory Medicine - Vimarsana News

Montreal Heart Institute: Results of the COLCORONA study published in The Lancet Respiratory Medicine

Colchicine could be considered as a treatment for non-hospitalized patients diagnosed with COVID-19 by PCR test and at risk of complicationsMONTREAL, May 28, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart